Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $52.2B |
| FY2017, ended Dec 31, 2017 | $57.5B |
| FY2018, ended Dec 31, 2018 | $47.1B |
| FY2019, ended Dec 31, 2019 | $52.3B |
| FY2020, ended Dec 31, 2020 | $60.0B |
| FY2021, ended Dec 31, 2021 | $85.2B |
| FY2022, ended Dec 31, 2022 | $46.9B |
| FY2023, ended Dec 31, 2023 | $41.5B |
| FY2024, ended Dec 31, 2024 | $53.0B |
| FY2025, ended Dec 31, 2025 | $73.5B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $65.0B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $149B |
| FY2017, ended Dec 31, 2017 | $146B |
| FY2018, ended Dec 31, 2018 | $147B |
| FY2019, ended Dec 31, 2019 | $137B |
| FY2020, ended Dec 31, 2020 | $122B |
| FY2021, ended Dec 31, 2021 | $127B |
| FY2022, ended Dec 31, 2022 | $157B |
| FY2023, ended Dec 31, 2023 | $172B |
| FY2024, ended Dec 31, 2024 | $187B |
| FY2025, ended Dec 31, 2025 | $185B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $187B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $9.43B | $8.22B |
| FY2017, ended Dec 31, 2017 | −$3.86B | $8.88B |
| FY2018, ended Dec 31, 2018 | $8.01B | $6.50B |
| FY2019, ended Dec 31, 2019 | $6.73B | $7.43B |
| FY2020, ended Dec 31, 2020 | $6.43B | $11.4B |
| FY2021, ended Dec 31, 2021 | $10.0B | $7.68B |
| FY2022, ended Dec 31, 2022 | $9.93B | $6.80B |
| FY2023, ended Dec 31, 2023 | $10.1B | $9.96B |
| FY2024, ended Dec 31, 2024 | $6.01B | $9.30B |
| FY2025, ended Dec 31, 2025 | $2.70B | $17.6B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.96B | $14.4B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $12.6B |
| FY2017, ended Dec 31, 2017 | $15.5B |
| FY2018, ended Dec 31, 2018 | $20.8B |
| FY2019, ended Dec 31, 2019 | $19.1B |
| FY2020, ended Dec 31, 2020 | $20.0B |
| FY2021, ended Dec 31, 2021 | $20.1B |
| FY2022, ended Dec 31, 2022 | $19.2B |
| FY2023, ended Dec 31, 2023 | $18.9B |
| FY2024, ended Dec 31, 2024 | $19.9B |
| FY2025, ended Dec 31, 2025 | $20.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $23.2B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $85.6B |
| FY2017, ended Dec 31, 2017 | $95.3B |
| FY2018, ended Dec 31, 2018 | $106B |
| FY2019, ended Dec 31, 2019 | $104B |
| FY2020, ended Dec 31, 2020 | $110B |
| FY2021, ended Dec 31, 2021 | $110B |
| FY2022, ended Dec 31, 2022 | $116B |
| FY2023, ended Dec 31, 2023 | $123B |
| FY2024, ended Dec 31, 2024 | $132B |
| FY2025, ended Dec 31, 2025 | $132B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | — |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 43.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.50B |
| FY2017, ended Dec 31, 2017 | 1.40B |
| FY2018, ended Dec 31, 2018 | 1.41B |
| FY2019, ended Dec 31, 2019 | 1.43B |
| FY2020, ended Dec 31, 2020 | 1.44B |
| FY2021, ended Dec 31, 2021 | 1.45B |
| FY2022, ended Dec 31, 2022 | 1.39B |
| FY2023, ended Dec 31, 2023 | 1.15B |
| FY2024, ended Dec 31, 2024 | 995M |
| FY2025, ended Dec 31, 2025 | 904M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 844M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.50B | $627M |
| FY2017, ended Dec 31, 2017 | $4.49B | $585M |
| FY2018, ended Dec 31, 2018 | $190M | $316M |
| FY2019, ended Dec 31, 2019 | $0 | $456M |
| FY2020, ended Dec 31, 2020 | $90.0M | $351M |
| FY2021, ended Dec 31, 2021 | $0 | $391M |
| FY2022, ended Dec 31, 2022 | $2.50B | $419M |
| FY2023, ended Dec 31, 2023 | $11.1B | $340M |
| FY2024, ended Dec 31, 2024 | $7.06B | $332M |
| FY2025, ended Dec 31, 2025 | $6.01B | $334M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $7.80B | — |
Valuation
At current price- Market Cap
- $67.9B
- P/E
- 17.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.4×
- Price / Book
- 1.1×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $187B
- Revenue Growth YoY
- −0.3%
- Revenue CAGR 3Y
- 5.7%
- Revenue CAGR 5Y
- 8.6%
- EPS Growth YoY
- −12.8%
- Net Income Growth YoY
- 29.9%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 2.3%
- Net Margin
- 2.1%
- FCF Margin
- 7.7%
- Return on Equity
- 6.1%
Earnings
Trailing 12 months- Net Income
- $3.96B
- EPS (diluted)
- $4.57
- EBITDA
- $16.3B
- Operating Income
- $4.34B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $23.2B
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $289B
- Total Liabilities
- $225B
- Shareholders' Equity
- $62.8B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $23.4B
- Capital Expenditure
- $9.02B
- Free Cash Flow
- $14.4B
Dividends and risk
Last 12 months- Dividend Yield
- 0.9%
- Dividend / Share
- $0.69
- Beta (5Y)
- 1.40
Every ratio is calculated from the company’s reported figures.